PATENT CLAIM ANALYSIS

Application Number: 15778368
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "218100"]

Abstract:
A highly safe dengue vaccine was invented that induced a neutralizing antibody response against all of the four serotypes of dengue virus without developing more than a fixed level of viremia with single administration. A tetravalent dengue virus formulation is provided that is excellent in both efficacy (neutralizing antibody response) and safety (viremia).

Claim (Index 29):
The attenuated serotype 3 dengue virus of  claim 24  wherein the mutation at position 209 is I209L, the mutation at position 582 is S582G, the mutation at position 1211 is F1211L, and the mutation at position 1563 is Q1563K.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.37209
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15195820', '11449876', '11453344', '13212845', '13281240']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7413513690223674
- 35 USC 102 Novelty (BERT): 0.5442136023197494
- Combined Prediction Score: 0.7216375923521057
- Mean Citation Score: 370.044854
- Max Citation Score: 379.45105
- Similarity Product: 288.74593365651367

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test